EGFR Antibodies in Colorectal Cancer: Where Do They Belong?

被引:34
作者
Grothey, Axel [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
PHASE-III TRIAL; 1ST-LINE TREATMENT; CETUXIMAB; PANITUMUMAB; FLUOROURACIL; BEVACIZUMAB; OXALIPLATIN; LEUCOVORIN; IRINOTECAN; CHEMOTHERAPY;
D O I
10.1200/JCO.2010.29.3407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4668 / 4670
页数:4
相关论文
共 18 条
[1]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[2]  
[Anonymous], J CLIN ONCOL S
[3]   Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer [J].
Banck, Michaela S. ;
Grothey, Axel .
CLINICAL CANCER RESEARCH, 2009, 15 (24) :7492-7501
[4]   Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer [J].
Bokemeyer, Carsten ;
Bondarenko, Igor ;
Makhson, Anatoly ;
Hartmann, Joerg T. ;
Aparicio, Jorge ;
de Braud, Filippo ;
Donea, Serban ;
Ludwig, Heinz ;
Schuch, Gunter ;
Stroh, Christopher ;
Loos, Anja H. ;
Zubel, Angela ;
Koralewski, Piotr .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) :663-671
[5]   Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study [J].
Douillard, Jean-Yves ;
Siena, Salvatore ;
Cassidy, James ;
Tabernero, Josep ;
Burkes, Ronald ;
Barugel, Mario ;
Humblet, Yves ;
Bodoky, Gyoergy ;
Cunningham, David ;
Jassem, Jacek ;
Rivera, Fernando ;
Kocakova, Ilona ;
Ruff, Paul ;
Blasinska-Morawiec, Maria ;
Smakal, Martin ;
Canon, Jean-Luc ;
Rother, Mark ;
Oliner, Kelly S. ;
Wolf, Michael ;
Gansert, Jennifer .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) :4697-4705
[6]   Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J].
Folprecht, Gunnar ;
Gruenberger, Thomas ;
Bechstein, Wolf O. ;
Raab, Hans-Rudolf ;
Lordick, Florian ;
Hartmann, Joerg T. ;
Lang, Hauke ;
Frilling, Andrea ;
Stoehlmacher, Jan ;
Weitz, Juergen ;
Konopke, Ralf ;
Stroszczynski, Christian ;
Liersch, Torsten ;
Ockert, Detlev ;
Herrmann, Thomas ;
Goekkurt, Eray ;
Parisi, Fabio ;
Koehne, Claus-Henning .
LANCET ONCOLOGY, 2010, 11 (01) :38-47
[7]   A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer [J].
Hecht, J. Randolph ;
Mitchell, Edith ;
Chidiac, Tarek ;
Scroggin, Carroll ;
Hagenstad, Christopher ;
Spigel, David ;
Marshall, John ;
Cohn, Allen ;
McCollum, David ;
Stella, Philip ;
Deeter, Robert ;
Shahin, Seta ;
Amado, Rafael G. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) :672-680
[8]   K-ras mutations and benefit from cetuximab in advanced colorectal cancer [J].
Karapetis, Christos S. ;
Khambata-Ford, Shirin ;
Jonker, Derek J. ;
O'Callaghan, Chris J. ;
Tu, Dongsheng ;
Tebbutt, Niall C. ;
Simes, R. John ;
Chalchal, Haji ;
Shapiro, Jeremy D. ;
Robitaille, Sonia ;
Price, Timothy J. ;
Shepherd, Lois ;
Au, Heather-Jane ;
Langer, Christiane ;
Moore, Malcolm J. ;
Zalcberg, John R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1757-1765
[9]  
MAUGHAN TS, 2010, J CLIN ONCOL S, V28, pS261
[10]   Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer [J].
Peeters, Marc ;
Price, Timothy Jay ;
Cervantes, Andres ;
Sobrero, Alberto F. ;
Ducreux, Michel ;
Hotko, Yevhen ;
Andre, Thierry ;
Chan, Emily ;
Lordick, Florian ;
Punt, Cornelis J. A. ;
Strickland, Andrew H. ;
Wilson, Gregory ;
Ciuleanu, Tudor-Eliade ;
Roman, Laslo ;
Van Cutsem, Eric ;
Tzekova, Valentina ;
Collins, Simon ;
Oliner, Kelly S. ;
Rong, Alan ;
Gansert, Jennifer .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) :4706-4713